These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37547534)

  • 1. Outcomes in ANCA-Associated Vasculitis in Scotland: Validation of the Renal Risk Score in a Complete National Cohort.
    McGovern DP; Lees JS; Traynor JP; Mackinnon B; Bell S; Hunter RW; Dhaun N; Metcalfe W; Kidder D; Lim M; Joss N; Kelly M; Taylor A; Cousland Z; Dey V; Buck K; Brix S; Geddes CC; McQuarrie EP; Stevens KI
    Kidney Int Rep; 2023 Aug; 8(8):1648-1656. PubMed ID: 37547534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a renal risk score in a cohort of children with ANCA-associated glomerulonephritis.
    Zhang P; Yao J; Gao CL; Fang X; Zhang ZQ; Xia ZK
    J Investig Med; 2023 Dec; 71(8):854-864. PubMed ID: 37615067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Kidney Prognostic Score in a Japanese Cohort of Patients With Antineutrophil Cytoplasmic Autoantibody Vasculitis.
    Takeda R; Takahashi K; Kronbichler A; Akiyama D; Hanai S; Kobayashi Y; Matsuki A; Umibe T; Ito C; Sugimoto T; Sugiyama T; Yoshida S; Nishio Y; Nukui I; Nakashima A; Wakabayashi H; Asanuma K; Furuta S; Nakajima H; Nakagomi D
    Kidney Int Rep; 2024 Mar; 9(3):611-623. PubMed ID: 38481514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome.
    Boudhabhay I; Delestre F; Coutance G; Gnemmi V; Quemeneur T; Vandenbussche C; Lazareth H; Canaud G; Tricot L; Gosset C; Hummel A; Terrier B; Rabant M; van Daalen EE; Wester Trejo MAC; Bajema IM; Karras A; Duong Van Huyen JP
    J Am Soc Nephrol; 2021 Sep; 32(9):2362-2374. PubMed ID: 34155059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analytical Accuracy of ANCA Renal Risk Score for Prediction of Renal Outcome in Patients With ANCA-Associated Glomerulonephritis.
    Xia M; Yu R; Zheng Z; Li H; Feng J; Xie X; Chen D
    Front Med (Lausanne); 2021; 8():736754. PubMed ID: 35071256
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of the Antineutrophil Cytoplasmic Antibody Renal Risk Score and Modification of the Score in a Chinese Cohort With a Majority of Myeloperoxidase-Positive Patients.
    Ni A; Chen L; Lan L; Wang Y; Ren P; Zhu Y; Xu Y; Shen X; Zhou Q; Huang X; Wang H; Chen J; Han F
    J Rheumatol; 2023 May; 50(5):662-670. PubMed ID: 36642437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement.
    Chu X; Hong Y; Wang Y; Yu C; Wang L; Tong H; Yan J; Zhang Z; Xu G; Yao Y; Zeng R
    Am J Nephrol; 2021; 52(12):899-908. PubMed ID: 34875652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Park PG; Pyo JY; Ahn SS; Song JJ; Park YB; Huh JH; Lee SW
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis Diagnosis.
    Brilland B; Boud'hors C; Copin MC; Jourdain P; Henry N; Wacrenier S; Djema A; Samoreau C; Coindre JP; Cousin M; Riou J; Croue A; Saint-André JP; Subra JF; Piccoli GB; Augusto JF
    Front Immunol; 2022; 13():834878. PubMed ID: 35392077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding 6-month parameters for the prediction of kidney prognosis in ANCA-associated glomerulonephritis.
    Boud'hors C; Riou J; Fage N; Samoreau C; Desouche A; Gatault P; Bridoux F; Martin C; Wacrenier S; Vinatier E; Djema A; Henry N; Croué A; Piccoli GB; Copin MC; Augusto JF; Brilland B;
    Clin Kidney J; 2023 Dec; 16(12):2530-2541. PubMed ID: 38046032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological prognostic factors in ANCA-associated glomerulonephritis.
    Boud'hors C; Copin MC; Wacrenier S; Piccoli GB; Croue A; Augusto JF; Brilland B
    Autoimmun Rev; 2022 Sep; 21(9):103139. PubMed ID: 35835443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified renal risk score for Chinese patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Wang RX; Wang JW; Li ZY; Chen SF; Yu XJ; Wang SX; Zhang F; Xiong ZY; Bi SH; Wang Y; Zhao MH; Chen M
    BMC Med; 2023 Feb; 21(1):45. PubMed ID: 36755282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis.
    Wacrenier S; Riou J; Jourdain P; Guibert F; Henry N; Djema A; Coindre JP; Crochette R; Cousin M; Croue A; Subra JF; Piccoli G; Augusto JF; Brilland B
    Nephrol Dial Transplant; 2022 May; 37(6):1078-1087. PubMed ID: 33856482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the risk factors for end‑stage renal disease and mortality in ANCA-associated vasculitis: a study from a single center of the Chinese Rheumatism Data Center.
    Guo Q; Yu L; Zhang X; Shang J; Duan X
    Clin Rheumatol; 2023 Feb; 42(2):489-499. PubMed ID: 36367596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
    Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
    J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of clinical and histological prognostic scores for kidney survival in ANCA-associated vasculitis.
    Sandino-Bermúdez MJ; Hernández-Andrade A; Hinojosa-Azaola A; Martín-Nares E; Mejía-Vilet JM
    Rheumatology (Oxford); 2024 Jun; ():. PubMed ID: 38876974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
    Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
    Front Immunol; 2022; 13():991469. PubMed ID: 36389826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement.
    Marco H; Draibe J; Villacorta J; Quintana LF; Martin N; Garcia-Osuna R; Cabre C; Martín-Gómez MA; Balius A; Saurina A; Picazo M; Gich-Saladich I; Navarro-Díaz M; Praga M; Cavero T; Ballarin J; Díaz-Encarnación MM;
    Clin Rheumatol; 2018 Apr; 37(4):1065-1074. PubMed ID: 29520673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.